Application 218543

Type: ANDA
Sponsor: MSN

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	MIRABEGRON	MIRABEGRON	TABLET, EXTENDED RELEASE;ORAL	25MG	No	No
002	MIRABEGRON	MIRABEGRON	TABLET, EXTENDED RELEASE;ORAL	50MG	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 2 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A218543-001	MIRABEGRON	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE / ORAL	AB		2025-11-04
A218543-002	MIRABEGRON	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE / ORAL	AB		2025-11-04

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 2 matching rows.

Application-product, TE code table
Application-product	TE code
A218543-001	AB
A218543-002	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A218543-001	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2025-11-04	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A218543-002	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2025-11-04	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A218543-001	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2025-11-04	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A218543-002	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2025-11-04	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A218543-001	MIRABEGRON	25MG	TABLET, EXTENDED RELEASE / ORAL	AB	2025-11-04	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A218543-002	MIRABEGRON	50MG	TABLET, EXTENDED RELEASE / ORAL	AB	2025-11-04	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A218543-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A218543-002	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A218543-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A218543-002	AB	1	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A218543-001	AB	1	`a50c72e98297…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A218543-002	AB	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Mirabegron	MIRABEGRON	Amneal Pharmaceuticals NY LLC	e597023d-6dcc-4d9e-8ce0-2d28a5d862f3	2026-03-26	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 218543 application number: ANDA218543